TRP'ing up chronic kidney disease-Reference-Cited by-同舟云学术

TRP'ing up chronic kidney disease

Published:2017-12-08 Issue:6368 Volume:358 Page:1256-1257
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Chung Jun-Jae¹,Shaw Andrey S.¹

Affiliation:

1. Research Biology, Genentech, South San Francisco, CA, USA.

Abstract

Blockade of a specific calcium channel can slow chronic kidney disease progression

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference13 articles.

1. The global burden of chronic kidney disease: estimates, variability and pitfalls

2. United States Renal Data System, “USRDS annual data report: Epidemiology of kidney disease in the United States” (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017).

3. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models

4. The role of the podocyte in albumin filtration

5. Podometrics as a Potential Clinical Tool for Glomerular Disease Management

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats;European Journal of Medicinal Chemistry;2024-09

2. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5;Kidney International;2023-06

3. Targeting ROS-sensitive TRP ion channels for relieving oxidative stress-related diseases based on nanomaterials;Materials Today Advances;2023-03

4. Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1 H ‐benzo[ d ]imidazoles as Potent and Selective Inhibitors;ChemMedChem;2022-05-24

5. Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors;Bioorganic & Medicinal Chemistry Letters;2022-04